Analysis of failure patterns in patients with resectable esophageal squamous cell carcinoma receiving chemoradiotherapy

被引:6
|
作者
Shen, Wen-Bin [1 ]
Zhu, Shu-Chai [1 ]
Gao, Hong-Mei [2 ]
Li, You-Mei [1 ]
Su, Jin-Wei [1 ]
Li, Juan [1 ]
Liu, Zhi-Kun [1 ]
机构
[1] Hebei Med Univ, Hosp 4, Dept Radiat Oncol, 12th Jiankan Rd, Shijiazhaung 050011, Peoples R China
[2] First Hosp Shijiazhaung, Dept Radiat, Shijiazhaung, Peoples R China
关键词
Chemoradiotherapy; esophageal squamous cell carcinoma; factor analysis; failure pattern; EXTENDED RADICAL ESOPHAGECTOMY; RADIATION-THERAPY; RECURRENCE; CANCER; RADIOTHERAPY; CHEMORADIATION; CHEMOTHERAPY; RESECTION;
D O I
10.4103/0973-1482.146128
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study investigates the failure pattern after chemoradiotherapy of patients with resectable esophageal squamous cell carcinoma (ESCC). Materials and Methods: We retrospectively analyzed 92 patients with T1-2, N0-1, and M0 ESCC. These patients were inoperable because of poor performance, comorbidities, poor tumor region, or refusal of operation. Results: Among the 92 patients, 29 cases displayed simple locoregional recurrence, 12 cases displayed simple distant metastasis, and 6 cases displayed distant metastasis with locoregional recurrence. Univariate analysis shows that the incidence of recurrence in the middle thoracic region was significantly higher than other regions (chi(2) = 14.415, P = 0.001). For the 18 patients with distant metastasis, incidence of distant metastasis in the lower thoracic region was significantly higher than the other regions (chi(2) = 39.359, P < 0.001). Among 35 cases with regional recurrence, 7 cases reached complete remission (14.6%) and 28 cases reached partial remission (PR; 63.6%) (chi(2) = 23.435, P < 0.001). Multivariate analysis shows that the patient age, tumor node metastasis (TNM) stage, and short-term efficacy were independent factors for locoregional recurrence. Patient age, TNM stage, X-ray length of the lesions, and short-term efficacy were the independent factors for distant metastases. Conclusion: The incidence of locoregional recurrence and distant metastasis in patients with upper thoracic esophageal cancer was lower than those who had middle thoracic and lower thoracic esophageal cancer. The incidence of locoregional recurrence and distant metastasis in patients who achieved complete response after treatment was low.
引用
收藏
页码:62 / 68
页数:7
相关论文
共 50 条
  • [21] The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma
    Park, Seong Yong
    Hong, Min Hee
    Kim, Hye Ryun
    Lee, Chang Geol
    Cho, Jae Ho
    Cho, Byoung Chul
    Kim, Dae Joon
    JOURNAL OF THORACIC DISEASE, 2020, 12 (11) : 6426 - 6434
  • [22] SALVAGE PHOTODYNAMIC THERAPY FOR PATIENTS WITH LOCAL FAILURE AFTER CHEMORADIOTHERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA
    Yano, Tomonori
    Hatogai, Ken
    Kojima, Takashi
    Yoda, Yusuke
    Morimoto, Hiroyuki
    Kaneko, Kazuhiro
    LASERS IN SURGERY AND MEDICINE, 2014, 46 : 46 - 46
  • [23] Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns
    Huang, Yu-Han
    Yeh, Chih-Hua
    Cheng, Nai-Ming
    Lin, Chien-Yu
    Wang, Hung-Ming
    Ko, Sheung-Fat
    Toh, Cheng-Hong
    Yen, Tzu-Chen
    Liao, Chun-Ta
    Ng, Shu-Hang
    PLOS ONE, 2017, 12 (07):
  • [24] Neoadjuvant chemoradiotherapy plus surgery in the treatment of potentially resectable thoracic esophageal squamous cell carcinoma
    Yan, Mao-Hui
    Hou, Xiao-Bin
    Cai, Bo-Ning
    Qu, Bao-Lin
    Dai, Xiang-Kun
    Liu, Fang
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (24) : 6315 - 6321
  • [25] Neoadjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Borderline Resectable Esophageal Squamous Cell Carcinoma
    Hosogi, Hisahiro
    Yoshida, Shinya
    Sakaguchi, Masazumi
    Kanaya, Seiichiro
    JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (12) : 3040 - 3042
  • [26] Neoadjuvant chemoradiotherapy plus surgery in the treatment of potentially resectable thoracic esophageal squamous cell carcinoma
    Mao-Hui Yan
    Xiao-Bin Hou
    Bo-Ning Cai
    Bao-Lin Qu
    Xiang-Kun Dai
    Fang Liu
    World Journal of Clinical Cases, 2020, (24) : 6315 - 6321
  • [27] Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma
    Yang, Guozhen
    Yue, Haodong
    Zhang, Xiaomin
    Zeng, Chufeng
    Tan, Linyu
    Zhang, Xu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [28] Neoadjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Borderline Resectable Esophageal Squamous Cell Carcinoma
    Hisahiro Hosogi
    Shinya Yoshida
    Masazumi Sakaguchi
    Seiichiro Kanaya
    Journal of Gastrointestinal Surgery, 2023, 27 : 3040 - 3042
  • [29] Survival analysis of 80 elderly patients with esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy with S-1
    Ran, J. -J.
    Shen, J. -J.
    Ma, J.
    Li, X. -Y.
    CANCER RADIOTHERAPIE, 2022, 26 (08): : 1064 - 1069
  • [30] Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal squamous cell carcinoma: A pooled analysis of randomized clinical trials
    Yang, Yang
    Shao, Rongjun
    Cao, Xiufeng
    Chen, Mengyuan
    Gong, Wangang
    Ying, Hangjie
    Song, Ge
    You, Guangxian
    Qiu, Guoqin
    Chen, Qixun
    Ji, Yongling
    Xu, Dong
    RADIOTHERAPY AND ONCOLOGY, 2024, 200